• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • All Drug Products
  • Diseases & Conditions
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Therapy Areas
  • Gastrointestinal
  • Omeprazole in the Long-Term Management of Duodenal Ulcers – A comparative study of omeprazole and ranitidine in high risk duodenal ulcer disease.

Disease
acid reflux
Drug Name
Losec
Generic Name
omeprazole
Sponsor
AstraZeneca
Drug Status
Approved Medicine
Phase
Other
Start Date
Jan 18, 1971
Study Name
I-598
Study Id
I-598
ClinicalTrials.gov ID
Not Applicable
Recruiting Status
Closed
Protocol Status
Not Available
Report
Jan 18, 1971
  • I-598.pdf (70 KB)

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2013